Glutamate: Difference between revisions

>Tracer
>Thomas
m Fixed an inaccuracy describing glutamate receptor categories; added citation.
Line 5: Line 5:
Because of its role in synaptic plasticity, glutamate is involved in cognitive functions such as learning and memory.<ref>McEntee, W. J., & Crook, T. H. (1993). Glutamate: its role in learning, memory, and the aging brain. Psychopharmacology, 111(4), 391-401. https://doi.org/10.1007/BF02253527. PMID 7870979.</ref>
Because of its role in synaptic plasticity, glutamate is involved in cognitive functions such as learning and memory.<ref>McEntee, W. J., & Crook, T. H. (1993). Glutamate: its role in learning, memory, and the aging brain. Psychopharmacology, 111(4), 391-401. https://doi.org/10.1007/BF02253527. PMID 7870979.</ref>


The receptors for glutamate fall into three major classes, known as AMPA receptors, [[NMDA receptor|NMDA receptors]], and metabotropic glutamate receptors.{{citation needed}}
The receptors for glutamate can be divided into metabotropic and ionotropic glutamate receptors. Ionotopic glutamate receptors fall into three major classes, known as AMPA receptors (GluA1-GluA4), [[NMDA receptor|NMDA receptors]] (GluN1-GluN3), and kainate receptors (GluK1-GluK5).{{citation needed}}<ref>Graham L. Collingridge, Richard W. Olsen, John Peters, Michael Spedding,
 
A nomenclature for ligand-gated ion channels,
 
Neuropharmacology,
 
Volume 56, Issue 1,
 
2009,
 
Pages 2-5,
 
ISSN 0028-3908,
 
<nowiki>https://doi.org/10.1016/j.neuropharm.2008.06.063</nowiki>.
 
(<nowiki>https://www.sciencedirect.com/science/article/pii/S0028390808002293</nowiki>)
 
Abstract: The ligand-gated ion channels that participate in fast synaptic transmission comprise the nicotinic acetylcholine, 5-hydroxytryptamine3 (5-HT3), γ-aminobutyric acidA (GABAA), glycine, ionotropic glutamate and P2X receptor families. A consistent and systematic nomenclature for the individual subunits that comprise these receptors and the receptors that result from their co-assembly is highly desirable. There is also a need to develop criteria that aid in deciding which of the vast number of heteromeric combinations of subunits that can be assembled in heterologous expression systems in vitro, are known, or likely, to exist as functional receptors in vivo. The aim of this short article is to summarize the progress being made by the nomenclature committee of IUPHAR (NC-IUPHAR) in formulating recommendations that attempt to address these issues.
 
Keywords: Ligand-gated ion channels; Nomenclature</ref>


Glutamate is a major constituent of a wide variety of proteins which makes it one of the most abundant amino acids in the human body.<ref>Meldrum BS (April 2000). "Glutamate as a neurotransmitter in the brain: review of physiology and pathology" (PDF). The Journal of Nutrition. 130 (4S Suppl): 1007S–15S. https://doi.org/10.1093/jn/130.4.1007s. PMID 10736372.</ref> It also serves as a metabolic precursor for the neurotransmitter [[GABA]], the main inhibitory neurotransmitter.
Glutamate is a major constituent of a wide variety of proteins which makes it one of the most abundant amino acids in the human body.<ref>Meldrum BS (April 2000). "Glutamate as a neurotransmitter in the brain: review of physiology and pathology" (PDF). The Journal of Nutrition. 130 (4S Suppl): 1007S–15S. https://doi.org/10.1093/jn/130.4.1007s. PMID 10736372.</ref> It also serves as a metabolic precursor for the neurotransmitter [[GABA]], the main inhibitory neurotransmitter.
Line 16: Line 36:


===Drugs targeting the glutamate system===
===Drugs targeting the glutamate system===
*'''Agonists'''
*'''Agonists'''
A glutamate [[agonist]] is a chemical that binds to and activates a glutamate [[receptor]] and triggers a response, displaying full efficacy at that receptor. An example of this is [[theanine]], a weak agonist of the NMDA receptor.<ref>Wakabayashi C, Numakawa T, Ninomiya M, Chiba S, Kunugi H (2012). "Behavioral and molecular evidence for psychotropic effects in L-theanine". Psychopharmacology (Berl.). 219 (4): 1099–109. PMID 21861094. https://doi.org/10.1007/s00213-011-2440-z</ref>
A glutamate [[agonist]] is a chemical that binds to and activates a glutamate [[receptor]] and triggers a response, displaying full efficacy at that receptor. An example of this is [[theanine]], a weak agonist of the NMDA receptor.<ref>Wakabayashi C, Numakawa T, Ninomiya M, Chiba S, Kunugi H (2012). "Behavioral and molecular evidence for psychotropic effects in L-theanine". Psychopharmacology (Berl.). 219 (4): 1099–109. PMID 21861094. https://doi.org/10.1007/s00213-011-2440-z</ref>
*'''Positive Allosteric Modulators'''
*'''Positive Allosteric Modulators'''
A positive allosteric modulator is a substance which indirectly influences the effects of an agonist at a receptor, by binding to a site distinct from that of the agonist binding site. They usually induce a structural change in the receptor structure.  
A positive allosteric modulator is a substance which indirectly influences the effects of an agonist at a receptor, by binding to a site distinct from that of the agonist binding site. They usually induce a structural change in the receptor structure.  
Many nootropics and ampakine (a class of compounds known to enhance attention span and alertness) drugs are positive modulators of the AMPA glutamate receptor. These include [[piracetam]], [[aniracetam]] and unifiram.
Many nootropics and ampakine (a class of compounds known to enhance attention span and alertness) drugs are positive modulators of the AMPA glutamate receptor. These include [[piracetam]], [[aniracetam]] and unifiram.
*'''Antagonists'''
*'''Antagonists'''
A glutamate receptor [[antagonist]] is a type of receptor drug that inhibits action at glutamate receptors. [[Alcohol|Ethanol]] acts as an antagonist of the NMDA, AMPA and kainate glutamate receptors, along with several antiepileptic drugs.{{citation needed}} The nootropic compound [[theanine]] is an antagonist of the AMPA and kainate receptors.<ref>Kakuda T (2002). "Neuroprotective effects of the green tea components theanine and catechins". Biol. Pharm. Bull. 25 (12): 1513–8. PMID 12499631. https://doi.org/10.1248/bpb.25.1513</ref> Many [[dissociatives|dissociative]] drugs are antagonists of the NMDA glutamate receptor, including [[ketamine]], [[MXE]], [[PCP]] and [[DXM]]. [[Tramadol]] and [[ibogaine]] are dual antagonists of the NMDA glutamate receptor and [[opioid]] receptors.{{citation needed}}  
A glutamate receptor [[antagonist]] is a type of receptor drug that inhibits action at glutamate receptors. [[Alcohol|Ethanol]] acts as an antagonist of the NMDA, AMPA and kainate glutamate receptors, along with several antiepileptic drugs.{{citation needed}} The nootropic compound [[theanine]] is an antagonist of the AMPA and kainate receptors.<ref>Kakuda T (2002). "Neuroprotective effects of the green tea components theanine and catechins". Biol. Pharm. Bull. 25 (12): 1513–8. PMID 12499631. https://doi.org/10.1248/bpb.25.1513</ref> Many [[dissociatives|dissociative]] drugs are antagonists of the NMDA glutamate receptor, including [[ketamine]], [[MXE]], [[PCP]] and [[DXM]]. [[Tramadol]] and [[ibogaine]] are dual antagonists of the NMDA glutamate receptor and [[opioid]] receptors.{{citation needed}}  
*'''Negative Allosteric Modulators'''
*'''Negative Allosteric Modulators'''
A negative allosteric modulator is a substance which indirectly influences the effects of an inverse agonist at a receptor, by binding to a site distinct from that of the inverse agonist binding site. Usually they induce a structural change in the receptor structure. Antiepileptic drugs are also found in this class.
A negative allosteric modulator is a substance which indirectly influences the effects of an inverse agonist at a receptor, by binding to a site distinct from that of the inverse agonist binding site. Usually they induce a structural change in the receptor structure. Antiepileptic drugs are also found in this class.


==See also==
==See also==
*[[Neurotransmitter]]
*[[Neurotransmitter]]
*[[Acetylcholine]]
*[[Acetylcholine]]
Line 36: Line 65:


==External links==
==External links==
*[[wikipedia:Glutamate|Glutamate (Wikipedia)]]
*[[wikipedia:Glutamate|Glutamate (Wikipedia)]]


==Literature==
==Literature==
* Meldrum, B. S. (2000). Glutamate as a neurotransmitter in the brain: review of physiology and pathology. The Journal of Nutrition, 130(4), 1007S-1015S. https://doi.org/10.1093/jn/130.4.1007s.
 
*Meldrum, B. S. (2000). Glutamate as a neurotransmitter in the brain: review of physiology and pathology. The Journal of Nutrition, 130(4), 1007S-1015S. https://doi.org/10.1093/jn/130.4.1007s.


==References==
==References==
Line 45: Line 76:
[[Category:Neurotransmitter]]
[[Category:Neurotransmitter]]
[[Category:Amino acid]]
[[Category:Amino acid]]
<references />